VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,314,727 | +24.7% | 1,565,209 | +28.5% | 0.01% | +20.0% |
| Q1 2023 | $8,268,977 | +244979.3% | 1,217,817 | +166.7% | 0.01% | +100.0% |
| Q4 2022 | $3,374 | -99.9% | 456,617 | +33.1% | 0.01% | 0.0% |
| Q3 2022 | $3,389,000 | +9.3% | 342,990 | +20.6% | 0.01% | +25.0% |
| Q2 2022 | $3,100,000 | +25.1% | 284,389 | +29.8% | 0.00% | +33.3% |
| Q1 2022 | $2,479,000 | -27.9% | 219,182 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,439,000 | -19.0% | 219,182 | -11.5% | 0.00% | -40.0% |
| Q3 2021 | $4,244,000 | – | 247,636 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |